SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, EAR, HYZN INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-Negative Breast Cancer Meets Primary Overall Response Rate Endpoint Pharmaceutical Investing
Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer Pharmaceutical Investing
BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights Pharmaceutical Investing
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference Pharmaceutical Investing
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025 Pharmaceutical Investing
Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, Upon Authorization or Approval Pharmaceutical Investing
Bristol Myers Squibb to Take Part in Wolfe Research Virtual Healthcare Conference Pharmaceutical Investing
Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials Pharmaceutical Investing
Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards Pharmaceutical Investing
Gilead to Present Data From Liver Disease Development Programs at The Liver Meeting® Pharmaceutical Investing
Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology Pharmaceutical Investing
